Radioimmunotherapy is a targeted molecular therapy that bears on radiobiologic and
immunologic processes, without crossresistance with other anticancer cytotoxic drugs. Since …

Over the last decade, Antibody Drug Conjugates (ADCs) have gained a great success due
to their documented clinical efficacy and manageable toxicity. Generally the word “drug” is …

Accrual Period: 3 years (approximately 1− 2 patients per month). Study Design: Phase I
dose escalation study with 225Ac− J591 using single dose regimen will be performed in …

Radioimmunotherapy has been in use for more than 20 years and has progressed
significantly since its efficacy has first been demonstrated in hematology. Yet it still has …

Some quite promising results have been also obtained in solid tumors despite their relative
radioresistance. For treatment of metastatic cancers, single-injection RIT is not realistic for a …

Résumé Le cancer de la prostate métastatique n'est que sensible transitoirement à la
chimiothérapie actuelle. La thérapie par des anticorps monoclonaux radiomarqués qui cible …